- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07279480
Communication and Health Investments for Elderly Women
December 1, 2025 updated by: Abdul Latif Jameel Poverty Action Lab
Household Communication and Health Investments for Elderly Women in Tamil Nadu
This study investigates how household communication plays a role in elderly women's take-up of health check-ups in rural Tamil Nadu, India.
First, we survey elders and their caretakers to measure demand for check-ups for elders.
We measure how interest in check-ups changes when we offer different versions of transportation support, to understand how much interest in check-ups are affected by the degree of caretaker involvement required.
Second, we conduct a randomized evaluation of interventions to improve take-up of free health check-ups at a nearby private hospital.
We will cross-randomize two interventions.
The first randomizes who is informed about the check-up: either only the elder is informed or both the elder and the caretaker are informed about the check-up.
The second randomizes whether free transportation is provided to and from the check-up.
We will measure take-up of the check-up.
We will also measure elders' willingness to mention the check-up to the caretaker.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
1200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jenny Wang
- Phone Number: 617-253-3807
- Email: wangjm@mit.edu
Study Locations
-
-
Tamil Nadu
-
Chennai, Tamil Nadu, India, 600018
- Recruiting
- JPAL SA at IFMR
-
Contact:
- Shrddha Rajesh
- Phone Number: +91 96770 25388
- Email: srajesh@povertyactionlab.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Elderly women aged 60-75
Exclusion Criteria:
- Those with severe hearing, speech, mental, or mobility impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Tell elder only, without transport (Control)
Elder is informed about the check-up.
No free arranged transportation offered.
|
|
|
Experimental: Tell elder only, with free transport
Elder is informed about the check-up.
We offer to arrange private transportation to and from the hospital at no cost.
|
We offer to arrange private transportation to and from the hospital at no cost.
|
|
Experimental: Tell elder and caretaker, without transport
Both elder and the caretaker are directly informed about the check-up.
No free arranged transportation offered.
|
Both elder and the caretaker are directly informed about the check-up.
|
|
Experimental: Tell elder and caretaker, with free transport
We offer to arrange private transportation to and from the hospital at no cost.
|
We offer to arrange private transportation to and from the hospital at no cost.
Both elder and the caretaker are directly informed about the check-up.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sign-up rates for check-up.
Time Frame: Assessed at 3 days after the intervention
|
This will be a measure of whether the elder is signed up for the check-up by the caretaker.
This will be measured either when the caretaker calls to reserve a spot for the elder or when the research team follows up with the household before the check-up.
|
Assessed at 3 days after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Elder attendance at check-up.
Time Frame: 1 week after the intervention
|
This is a measure of whether the elder shows up to the health check-up at the end of the week.
Attendance at the health check-up will be measured by surveyors at the hospital, about 1 week after the health check-up invitations are shared with households.
|
1 week after the intervention
|
|
Elder willingness to mention check-up to caretaker
Time Frame: Assessed 2 days after the intervention
|
This is a measure of whether elder chooses to mention check-up to caretaker when offered.
Among elders in households that are randomized into the "Tell elder only" arm, we will offer to inform the caretaker of the check-up on behalf of the elder and record whether the elder was willing to have us mention the check-up as one of our outcomes.
|
Assessed 2 days after the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 10, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
October 1, 2026
Study Registration Dates
First Submitted
December 1, 2025
First Submitted That Met QC Criteria
December 1, 2025
First Posted (Actual)
December 12, 2025
Study Record Updates
Last Update Posted (Actual)
December 12, 2025
Last Update Submitted That Met QC Criteria
December 1, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 2505001660
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Take-up of Preventative Care
-
University of MichiganCompletedThe Study is Intended to Increase Take-up of EITCUnited States
-
University Hospitals Cleveland Medical CenterRecruiting
-
University Hospital, Strasbourg, FranceUnknownFollow-up CareFrance
-
Massachusetts General HospitalConquer Cancer FoundationCompletedCancer | Advanced Cancer | Consultation, Remote | Follow-Up CareUnited States
-
University of UtahCenters for Disease Control and Prevention; Utah Department of HealthCompletedUp-to-date Immunization Status for Children in Child CareUnited States
-
Meyer Children's Hospital IRCCSCompletedPediatric Cancer | Follow-up CareItaly
-
Keele UniversityCompletedPatient Acceptability to Being Invited to Take Part in Research of Relevance to ThemUnited Kingdom
-
International Centre for Diarrhoeal Disease Research...CompletedFollow-up of a cRCTBangladesh
-
Université de Reims Champagne-ArdenneNot yet recruitingMedical Follow-up of Medical SecretariesFrance
-
Emre SezginRecruitingCaregiver Burden | Social Needs Status | Unmet Health-Related Social Needs and Access to Community Resources | Primary Health Care and Access to Primary Care | Technology Use to Support Caregivers | Health Status, Child and Infant Care | Preventative Care ServicesUnited States
Clinical Trials on Free Transport
-
University Hospital, RouenRecruitingThrombotic MicroangiopathiesFrance, Martinique, Reunion
-
University of California, DavisTobacco Related Disease Research Program; Los Angeles County Department of... and other collaboratorsCompletedSmoking Cessation CounsellingUnited States
-
Eda Cetin OzdemirCompletedNdirectly Measuring the Difference Between the Free Gingival Graft and the Free Gingival Unit Via a ScannerTurkey
-
University of Sao PauloUniversidade Estadual de MaringáActive, not recruiting
-
Karadeniz Technical UniversityThe Scientific and Technological Research Council of TurkeyCompletedNutrition | Autism Spectrum Disorder (ASD)Turkey (Türkiye)
-
Bezmialem Vakif UniversityNot yet recruiting
-
Glorian SorensenHealis-Sekhsaria Institute for Public HealthCompletedTobacco Use CessationUnited States, India
-
University of British ColumbiaRecruitingHead and Neck Neoplasms | Pharyngectomy | Reconstructive Surgical ProceduresCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic SyndromeUnited States